Takeda Pharmaceutical Company Limited (TYO:4502)
4,382.00
-85.00 (-1.90%)
Mar 31, 2025, 11:30 AM JST
TYO:4502 Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 28, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Market Capitalization | 6,832,268 | 6,564,378 | 6,762,204 | 5,423,454 | 6,229,971 | 5,153,364 | Upgrade
|
Market Cap Growth | 4.20% | -2.93% | 24.68% | -12.95% | 20.89% | -26.69% | Upgrade
|
Enterprise Value | 11,770,388 | 11,482,982 | 10,868,028 | 9,054,481 | 10,862,765 | 10,199,254 | Upgrade
|
Last Close Price | 4467.00 | 3999.26 | 3989.34 | 3065.86 | 3323.88 | 2638.83 | Upgrade
|
PE Ratio | 34.32 | 45.57 | 21.33 | 23.57 | 16.57 | 116.48 | Upgrade
|
Forward PE | 32.81 | 31.03 | 21.61 | 14.12 | 18.44 | - | Upgrade
|
PS Ratio | 1.54 | 1.54 | 1.68 | 1.52 | 1.95 | 1.57 | Upgrade
|
PB Ratio | 0.95 | 0.90 | 1.06 | 0.95 | 1.20 | 1.09 | Upgrade
|
P/FCF Ratio | 7.45 | 12.14 | 8.08 | 5.42 | 6.92 | 9.50 | Upgrade
|
P/OCF Ratio | 5.95 | 9.16 | 6.92 | 4.83 | 6.16 | 7.69 | Upgrade
|
PEG Ratio | 4.58 | 18.99 | 2.83 | - | 0.33 | - | Upgrade
|
EV/Sales Ratio | 2.57 | 2.69 | 2.70 | 2.54 | 3.40 | 3.10 | Upgrade
|
EV/EBITDA Ratio | 8.94 | 10.09 | 8.98 | 7.65 | 11.04 | 11.59 | Upgrade
|
EV/EBIT Ratio | 19.94 | 23.28 | 17.54 | 15.09 | 25.62 | 34.38 | Upgrade
|
EV/FCF Ratio | 12.83 | 21.23 | 12.99 | 9.06 | 12.07 | 18.80 | Upgrade
|
Debt / Equity Ratio | 0.73 | 0.75 | 0.77 | 0.85 | 0.98 | 1.16 | Upgrade
|
Debt / EBITDA Ratio | 4.13 | 4.60 | 3.86 | 4.07 | 5.16 | 6.21 | Upgrade
|
Debt / FCF Ratio | 5.92 | 10.10 | 5.81 | 4.81 | 5.64 | 10.07 | Upgrade
|
Asset Turnover | 0.31 | 0.29 | 0.30 | 0.27 | 0.25 | 0.25 | Upgrade
|
Inventory Turnover | 1.31 | 1.30 | 1.36 | 1.40 | 1.34 | 1.33 | Upgrade
|
Quick Ratio | 0.59 | 0.50 | 0.49 | 0.73 | 1.00 | 0.65 | Upgrade
|
Current Ratio | 1.31 | 1.11 | 0.97 | 1.21 | 1.53 | 1.14 | Upgrade
|
Return on Equity (ROE) | 2.94% | 2.12% | 5.27% | 4.24% | 7.60% | 0.89% | Upgrade
|
Return on Assets (ROA) | 2.51% | 2.12% | 2.85% | 2.88% | 2.06% | 1.39% | Upgrade
|
Return on Capital (ROIC) | 2.97% | 2.57% | 3.57% | 3.62% | 2.59% | 1.74% | Upgrade
|
Return on Capital Employed (ROCE) | 4.50% | 3.90% | 5.40% | 5.40% | 3.80% | 2.80% | Upgrade
|
Earnings Yield | 3.05% | 2.20% | 4.69% | 4.24% | 6.04% | 0.86% | Upgrade
|
FCF Yield | 13.42% | 8.24% | 12.37% | 18.44% | 14.44% | 10.53% | Upgrade
|
Dividend Yield | 4.39% | 4.70% | 4.51% | 5.87% | 5.42% | 6.82% | Upgrade
|
Payout Ratio | 145.09% | 199.34% | 88.14% | 123.30% | 75.36% | 638.73% | Upgrade
|
Buyback Yield / Dilution | -1.17% | -0.67% | 0.46% | -0.23% | -0.47% | -61.98% | Upgrade
|
Total Shareholder Return | 3.21% | 4.03% | 4.98% | 5.64% | 4.95% | -55.16% | Upgrade
|
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.